2026 half year results
Today's results reinforce that Medibank is a growing health company, with our customers increasingly recognising the value and health and wellbeing support we provide.
Changes to Executive Leadership team
CEO Craig Drummond announced changes to the Executive Leadership Team to deliver on Medibank's commitment to improving customer experience outcomes.
Medibank appoints John Goodall, EGM Technology & Operations
John Goodall will take up the Executive Committee role of Executive General Manager Technology & Operations.
Full Year Results FY16
Group NPAT of $417.6 million, up 46.4% from $285.3 million in FY15. Final dividend of 6.0 cents per share, fully franked
2026 half year results
Today's results reinforce that Medibank is a growing health company, with our customers increasingly recognising the value and health and wellbeing support we provide.
Changes to Executive Leadership team
CEO Craig Drummond announced changes to the Executive Leadership Team to deliver on Medibank's commitment to improving customer experience outcomes.
Medibank appoints John Goodall, EGM Technology & Operations
John Goodall will take up the Executive Committee role of Executive General Manager Technology & Operations.
Full Year Results FY16
Group NPAT of $417.6 million, up 46.4% from $285.3 million in FY15. Final dividend of 6.0 cents per share, fully franked